COVID-19 vaccine-related axillary edema in breast imaging setting

Vivianne Freitas; Sandeep Ghai; Frederick Au; Supriya Kulkarni; Heather Michelle Ruff; Karina Bukhanov

doi:10.1016/j.radcr.2021.11.075

COVID-19 vaccine-related axillary edema in breast imaging setting

Radiol Case Rep. 2022 Mar;17(3):775-778. doi: 10.1016/j.radcr.2021.11.075. Epub 2021 Dec 28.

Authors

Vivianne Freitas¹, Sandeep Ghai¹, Frederick Au¹, Supriya Kulkarni¹, Heather Michelle Ruff^{2

3}, Karina Bukhanov¹

Affiliations

¹ University of Toronto, Joint Department of Medical Imaging, University Health Network, Sinai Health System, Women's College Hospital, 610 University Avenue - M5G 2M9, Toronto, Ontario, Canada.
² Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
³ Laboratory Medicine Program, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Abstract

Worldwide, many vaccines have been developed in response to the COVID-19 pandemic. Unilateral reactive axillary adenopathy related to the COVID-19 vaccine is a well-known occurrence. In addition, axillary edema has also been observed following COVID-19 vaccinations in patients undergoing breast MRI, and radiologists need to be aware of this possibility to avoid performing unnecessary work-up that can be costly to the health care system and be stressful for patients.

Publication types

Case Reports